Global Fedratinib Market is projected to grow from USD 158.7 million in 2025 to USD 285.4 million by 2032, driven by rising myelofibrosis cases, expanding JAK2 inhibitor adoption, and ongoing clinical research. Sample: https://www.24chemicalresearch.com/download-sample/228608/fedratinib-market Full Report: https://www.24chemicalresearch.com/reports/228608/fedratinib-market #Fedratinib,#Pharmaceuticals,#Oncology,#JAKInhibitors,#Myelofibrosis,#Biotech,#MarketResearch